Contract Research Stocks Scatter Chart

12 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 12 Contract Research stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 6.2% and the median P/E 33.90. Pinned to the edge: 2 outliers on X and 1 on Y.

Rank correlation -0.16 Trend R² 0.00 X middle half 2.5% to 11.7% Y middle half 25.48 to 38.86
3High Revenue Growth (1y) (TTM), high P/E
3Low Revenue Growth (1y) (TTM), high P/E
3Low Revenue Growth (1y) (TTM), low P/E
3High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

12 plotted
# Industry
1 TMOThermo Fisher Scientific 8.3% 36.63 $259.44B Life Sciences Tools
2 IQVIqvia Holdings 8.8% 31.30 $43.67B Contract Research
3 LHLabcorp Holdings 6.0% 29.94 $30.09B Diagnostic Labs
4 MEDPMedpace Holdings 20.4% 35.28 $18.29B Contract Research
5 CRLCharles River Laboratories International -1.2% 402.10OUT $16.18B Contract Research
6 LDOSLeidos Holdings 2.7% 11.41 $15.93B Defense
7 ICLRIcon 1.8% 34.02 $14.90B Contract Research
8 RDYDr Reddys Laboratories -10.5% 33.78 $12.31B Generic Drugs
9 DVADavita 6.4% 12.11 $11.06B Healthcare Services
10 CAICaris Life Sciences 61.5%OUT 68.09 $6.61B Diagnostic Labs
11 WDHWaterdrop 76.3%OUT 6.31 $360.88M Insurance Brokers
12 PBSVPharma-Bio Serv 3.3% 45.53 $11.45M Consulting

Frequently Asked Questions

Which Contract Research stocks look cheap relative to their growth?

Among Contract Research stocks, the largest companies growing revenue faster than the median (6.2%) while trading below the median P/E (33.90) are Iqvia Holdings (IQV), Davita (DVA) and Waterdrop (WDH). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Contract Research stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Charles River Laboratories International (CRL), Icon (ICLR) and Pharma-Bio Serv (PBSV).

What is the median P/E of Contract Research stocks?

The median P/E across the 12 Contract Research stocks plotted is 33.90, with the middle half between 25.48 and 38.86.

What is the median Revenue Growth (1y) (TTM) of Contract Research stocks?

The median is 6.2%, with the middle half between 2.5% and 11.7%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Contract Research stocks?

The rank correlation (Spearman) is -0.16, a weak negative relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a lower P/E.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 2 companies are outliers on Revenue Growth (1y) (TTM) and 1 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.